Company / EPS (Diluted)
SOLENO THERAPEUTICS INC EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.39
FY2025
5-year range
-$5.81 / $0.39
FY2021-FY2025
Trend
+108.9%
vs FY2024
Sector context
#36 of 204
Health Care
What the data says
SOLENO THERAPEUTICS INC's eps (diluted) of $0.39 is higher than 82% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 6 years, ranging from $-5.81 in FY2021 to $0.39 in FY2025.
Based on SEC 10-K filings.
0.39 in FY2025. Top quartile in the Health Care sector.
Improved from $-2.36 to $0.39 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 204This company $0.39 Sector average -$1.03
▼
+137.8% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 108.9% year-over-year.
- Ranks #36 out of 204 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.39 | +108.9% |
| FY2024 | -$4.38 | -85.6% |
| FY2023 | -$2.36 | +17.8% |
| FY2022 | -$2.87 | +50.6% |
| FY2021 | -$5.81 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | -$1.69 | +83.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026